BOSTON (AP) — BOSTON (AP) — Haemonetics Corp. (HAE) on Thursday reported fiscal second-quarter profit of $38.7 million.
On a per-share basis, the Boston-based company said it had net income of 81 cents. Earnings, adjusted for amortization costs and asset impairment costs, came to $1.27 per share.
The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of $1.12 per share.
The provider blood management systems for health care providers and blood collectors posted revenue of $327.3 million in the period, also exceeding Street forecasts. Four analysts surveyed by Zacks expected $311.1 million.
Haemonetics expects full-year earnings in the range of $4.80 to $5 per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HAE at https://www.zacks.com/ap/HAE
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
